KeyBanc raised the firm’s price target on ICU Medical (ICUI) to $175 from $173 on higher estimates, while keeping an Overweight rating on the shares. The firm remains encouraged by ICU’s underlying operational progress as well as ability to raise 2025 EPS/EBITDA guidance, despite continued macro headwinds.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: